Agios Pharmaceuticals Stock Price. Everything You Need To Know About The Agios Pharmaceuticals Stock!
Agios Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 389 full-time employees. The company went IPO on 2013-07-24. The firm’s lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of a- and b-thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The firm is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD and anemia associated with low-to intermediate-risk myelodysplastic syndrome (LR MDS), and hemolytic anemias.
Agios Pharmaceuticals Stock Price. Everything You Need To Know About The Agios Pharmaceuticals Stock! performance
- Employees 389
- Company HQ Cambridge
- Website https://www.agios.com/
- AGIO Asset Type Common Stock
- AGIO Market Capitalization 1.9B
- Earnings Per Share -6.33
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Agios Pharmaceuticals is a leading biopharmaceutical company that specializes in developing novel medicines for patients with genetically defined diseases. With a focus on cellular metabolism, Agios aims to transform the way diseases are treated and bring hope to patients in need. As an investor from Malaysia, Thailand, Indonesia, or Vietnam, you can participate in the growth of Agios Pharmaceuticals by investing in its stocks through Zorion. With Zorion’s user-friendly platform, you can easily access real US stocks and Pre-IPO companies, including Agios Pharmaceuticals. Gain investment insights and recommendations to make informed decisions, and access educational materials to enhance your investment knowledge. Start investing in Agios Pharmaceuticals today with Zorion and make your mark in the world of biopharmaceuticals.
